Baumal Caroline 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
Baumal Caroline
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-01-04$60.05/sh−2,751$165,207→ 32,931.37 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on a Restricted Stock Unit release.